188 related articles for article (PubMed ID: 1917993)
1. Conversion of 1-O-[3H]alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils.
Venable ME; Nieto ML; Schmitt JD; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18691-8. PubMed ID: 1917993
[TBL] [Abstract][Full Text] [Related]
2. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
3. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
4. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.
Chilton FH; Ellis JM; Olson SC; Wykle RL
J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation.
Venable ME; Olson SC; Nieto ML; Wykle RL
J Biol Chem; 1993 Apr; 268(11):7965-75. PubMed ID: 8463317
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes.
Ramesha CS; Pickett WC
J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991
[TBL] [Abstract][Full Text] [Related]
7. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
8. A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway.
Uemura Y; Lee TC; Snyder F
J Biol Chem; 1991 May; 266(13):8268-72. PubMed ID: 2022643
[TBL] [Abstract][Full Text] [Related]
9. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
10. The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity.
Blank ML; Smith ZL; Fitzgerald V; Snyder F
Biochim Biophys Acta; 1995 Feb; 1254(3):295-301. PubMed ID: 7857969
[TBL] [Abstract][Full Text] [Related]
11. Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide.
Svetlov SI; Liu H; Chao W; Olson MS
Biochim Biophys Acta; 1997 Jun; 1346(2):120-30. PubMed ID: 9219895
[TBL] [Abstract][Full Text] [Related]
12. Metabolic fate of platelet-activating factor in neutrophils.
Chilton FH; O'Flaherty JT; Ellis JM; Swendsen CL; Wykle RL
J Biol Chem; 1983 May; 258(10):6357-61. PubMed ID: 6853486
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2.
Kramer RM; Jakubowski JA; Deykin D
Biochim Biophys Acta; 1988 Apr; 959(3):269-79. PubMed ID: 3355850
[TBL] [Abstract][Full Text] [Related]
14. CD2 triggering stimulates the formation of platelet-activating factor-acether from alkyl-arachidonoyl-glycerophosphocholine in a human CD4+ T lymphocyte clone.
Le Gouvello S; Vivier E; Debre P; Thomas Y; Colard O
J Immunol; 1992 Aug; 149(4):1289-93. PubMed ID: 1354232
[TBL] [Abstract][Full Text] [Related]
15. Comparison of acceptor and donor substrates in the CoA-independent transacylase reaction in human neutrophils.
Nixon AB; Greene DG; Wykle RL
Biochim Biophys Acta; 1996 May; 1300(3):187-96. PubMed ID: 8679683
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of arachidonic acid into 1-acyl-2-lyso-sn-glycero-3-phosphocholine of the human neutrophil.
Chilton FH; Hadley JS; Murphy RC
Biochim Biophys Acta; 1987 Jan; 917(1):48-56. PubMed ID: 3098298
[TBL] [Abstract][Full Text] [Related]
17. Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils.
Chilton FH; O'Flaherty JT; Ellis JM; Swendsen CL; Wykle RL
J Biol Chem; 1983 Jun; 258(12):7268-71. PubMed ID: 6408071
[TBL] [Abstract][Full Text] [Related]
18. Generation of the precursor (lyso-PAF) of platelet-activating factor via a CoA-dependent transacylase.
Blank ML; Fitzgerald V; Smith ZL; Snyder F
Biochem Biophys Res Commun; 1995 May; 210(3):1052-8. PubMed ID: 7763233
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product.
Malone B; Lee T; Snyder F
J Biol Chem; 1985 Feb; 260(3):1531-4. PubMed ID: 3918041
[TBL] [Abstract][Full Text] [Related]
20. Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18).
Triggiani M; Chilton FH
Biochim Biophys Acta; 1989 Nov; 1006(1):41-51. PubMed ID: 2572273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
